S1411
Interdisciplinary - Health economics & health services research
ESTRO 2026
Purpose/Objective: The OligoCare project is an observational study activated under the E ² -RADiatE platform. This European cohort study at the time of analysis had enrolled 3,167 patients across 10 countries through the collaboration of ESTRO and EORTC. Although the project received financial support from various sources, this funding primarily covered central coordination and platform management. No direct compensation was provided to participating centers for their involvement. As a result, the scientific and operational contributions from clinical teams and experts, essential to the study’s success, exceeded the financial support available. This analysis aimed to quantify these in-kind contributions to inform future funding models and ensure appropriate recognition of academic and clinical efforts. Material/Methods: The uncompensated professional efforts were defined as the sum of two components: the time invested by clinical staff at accrual centers for patient management and data collection, and the time dedicated by Principal Investigators and Steering Committee members to protocol development, oversight, and coordination. An additional 15% overhead was applied to account for indirect, non- itemized efforts such as institutional support, administrative communication, and travel time.Accrual center costs (ACC) were calculated based on the average time per patient for baseline data collection (BSD) and follow-up visits (FUP), with an estimated three FUPs per patient. A detailed questionnaire was distributed to the top enrolling centre in each country to assess time spent per professional role and corresponding hourly rates. Compensation estimates were cross-referenced with OECD’s Health at a Glance 2023 and EUROSTAT wage data (as of August 2025), incorporating national wage multipliers for medical professionals. Committee costs (CC) were derived from EORTC records of 15 Steering Committee meetings, including time spent on protocol development, follow-up, and wrap-up activities. Results: Data from centers accounting for 1785 patients (55% of total accrual) revealed an average of 211 minutes per patient (range:105–390), corresponding to a mean cost of € 257 (range: € 75–436, Figure 1 for details). The total estimated ACC was € 782,000 (Table 1). Committee-related efforts were valued at € 147,300. Including overheads, the total in-kind contribution of the community reached approximately € 1.068.700, nearly matches central coordination costs ( € 825,500). Conclusion: This analysis shows that uncompensated professional efforts are a major resource in large academic studies. The community’s estimated contribution ( € 1,068,700) underscoring the vital yet under-recognized role of
academic and clinical teams. Quantifying these efforts supports fair recognition and sustainable funding for international research. Keywords: Cost Analysis, Oligocare , In-kind contribution Digital Poster 3023 Impact of Italy’s National Recovery and Resilience Plan on SBRT technology adoption in public radiotherapy centers: a national survey analysis Edoardo Mastella 1 , Paolo Caricato 2 , Nicola Padula 3 , Alessandro Scaggion 2 , Francesca Romana Giglioli 4 , Serenella Russo 5 , Pietro Mancosu 6,7 1 Medical Physics Unit, University Hospital of Ferrara, Ferrara, Italy. 2 Medical Physics Department, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy. 3 Medical Physics Department, Michele e Pietro Ferrero Hospital (ASL CN2), Cuneo, Italy. 4 Medical Physics Unit, AOU Città della Salute e della Scienza, Torino, Italy. 5 Medical Physics Unit, AUSL Toscana Centro, Firenze, Italy. 6 Medical Physics Unit, IRCCS Humanitas Research Hospital, Rozzano (MI), Italy. 7 Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy Purpose/Objective: The Stereotactic Body RadioTherapy (SBRT) Working Group of the Italian Association of Medical Physics conducted a nationwide survey to assess how investments from Italy’s National Recovery and Resilience Plan (NRRP)-the EU-funded Next Generation EU program driving post-pandemic renewal and innovation-have influenced the adoption and upgrading of SBRT technology in public radiotherapy centers with different levels of experience and resource. Material/Methods: Between January and June 2025, an online survey was distributed to all Italian medical physics units performing radiotherapy. The questionnaire explored SBRT technology needs and recent acquisitions focusing on four SBRT-related technological domains considered essential for advanced SBRT delivery: (i) C- arm linear accelerators, (ii) 4D imaging/respiratory motion management, (iii) surface-guided RT (SGRT), and (iv) in vivo dosimetry. For each category, centers were asked to report both their pre-NRRP needs and whether new acquisitions had been supported by NRRP funding. Data were analyzed across all respondents and stratified by volume of SBRT patients treated per year, experience, and baseline technological levels as of 2022. Results: Sixty-nine centers responded, including 59 public centers eligible for NRRP funding.
Made with FlippingBook - Share PDF online